Poly-D,L-Lactic Acid Filler Attenuates Ultraviolet B-Induced Skin Pigmentation by Reducing Destruction of the Basement Membrane

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Nov 9

PMID 39519119

Authors

Kyung-A Byun

Suk Bae Seo

Seyeon Oh

Jong-Won Jang

Kuk Hui Son

Kyunghee Byun

Affiliations

Soon will be listed here.

Abstract

Poly-D,L-lactic acid (PDLLA) filler, which increases volume and collagen synthesis, is used for skin rejuvenation. PDLLA filler also increases M2 macrophages and IL-10. Ultraviolet (UV) radiation induces dermal hyperpigmentation by disrupting the basement membrane (BM), allowing melanin to move into the dermis. Therefore, using UV-irradiated macrophages and animal skin, we determined whether PDLLA filler decreased M1 macrophages and skin inflammation, thereby reducing BM destruction and dermal hyperpigmentation. UV radiation increased the M1 macrophage marker CD86 and TNF-α expression, which was inhibited by the treatment of macrophages with PDLLA. In fibroblasts treated with conditioned medium from UV-irradiated macrophages, NF-κB activity, NLRP3 inflammasome components (NLRP3, ASC, and pro-caspase-1), IL-18, MMP2, and MMP9 increased, but all decreased after PDLLA treatment. Similar to the in vitro study, UV-irradiated mouse skin showed increased CD86, NLRP3, ASC, pro-caspase-1, MMP2, and MMP9, which decreased after PDLLA injection. Disruption of the lamina densa of the BM and dermal pigmentation increased after UV irradiation and decreased after PDLLA injection. In conclusion, PDLLA reduced dermal pigmentation by decreasing BM destruction in UV-irradiated skin. PDLLA has the potential to reduce dermal pigmentation by regenerating the BM.

References

Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer H . The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol. 2007; 17(13):1140-5. DOI: 10.1016/j.cub.2007.05.074. View

Tanaka K, Hasegawa J, Asamitsu K, Okamoto T . Prevention of the ultraviolet B-mediated skin photoaging by a nuclear factor kappaB inhibitor, parthenolide. J Pharmacol Exp Ther. 2005; 315(2):624-30. DOI: 10.1124/jpet.105.088674. View

Hasegawa T, Nakashima M, Suzuki Y . Nuclear DNA damage-triggered NLRP3 inflammasome activation promotes UVB-induced inflammatory responses in human keratinocytes. Biochem Biophys Res Commun. 2016; 477(3):329-35. DOI: 10.1016/j.bbrc.2016.06.106. View

Grimes P . Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009; 28(2):77-85. DOI: 10.1016/j.sder.2009.04.001. View

Nakajima H, Ezaki Y, Nagai T, Yoshioka R, Imokawa G . Epithelial-mesenchymal interaction during UVB-induced up-regulation of neutral endopeptidase. Biochem J. 2012; 443(1):297-305. DOI: 10.1042/BJ20111876. View

Gilchrest B, Fitzpatrick T, Anderson R, Parrish J . Localization of malanin pigmentation in the skin with Wood's lamp. Br J Dermatol. 1977; 96(3):245-8. DOI: 10.1111/j.1365-2133.1977.tb06132.x. View

Bond M, Fabunmi R, Baker A, Newby A . Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998; 435(1):29-34. DOI: 10.1016/s0014-5793(98)01034-5. View

Horiba S, Kawamoto M, Tobita R, Kami R, Ogura Y, Hosoi J . M1/M2 Macrophage Skewing is Related to Reduction in Types I, V, and VI Collagens with Aging in Sun-Exposed Human Skin. JID Innov. 2023; 3(6):100222. PMC: 10542643. DOI: 10.1016/j.xjidi.2023.100222. View

Sofen B, Prado G, Emer J . Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion. Skin Therapy Lett. 2016; 21(1):1-7. View

10.

Wu X, Masedunskas A, Weigert R, Copeland N, Jenkins N, Hammer J . Melanoregulin regulates a shedding mechanism that drives melanosome transfer from melanocytes to keratinocytes. Proc Natl Acad Sci U S A. 2012; 109(31):E2101-9. PMC: 3412008. DOI: 10.1073/pnas.1209397109. View

11.

CRUICKSHANK C, HARCOURT S . PIGMENT DONATION IN VITRO. J Invest Dermatol. 1964; 42:183-4. DOI: 10.1038/jid.1964.39. View

12.

Wang Y, Smith W, Hao D, He B, Kong L . M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds. Int Immunopharmacol. 2019; 70:459-466. DOI: 10.1016/j.intimp.2019.02.050. View

13.

DOrazio J, Jarrett S, Amaro-Ortiz A, Scott T . UV radiation and the skin. Int J Mol Sci. 2013; 14(6):12222-48. PMC: 3709783. DOI: 10.3390/ijms140612222. View

14.

Beasley K, Weiss M, Weiss R . Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg. 2009; 25(2):86-94. DOI: 10.1055/s-0029-1220647. View

15.

Tang L, Zhou F . Inflammasomes in Common Immune-Related Skin Diseases. Front Immunol. 2020; 11:882. PMC: 7247819. DOI: 10.3389/fimmu.2020.00882. View

16.

Lee K, Chan L, Lee A, Lee C, Wong S, Yi K . Poly-d,l-lactic Acid (PDLLA) Application in Dermatology: A Literature Review. Polymers (Basel). 2024; 16(18). PMC: 11434839. DOI: 10.3390/polym16182583. View

17.

Passeron T, Genedy R, Salah L, Fusade T, Kositratna G, Laubach H . Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology. J Eur Acad Dermatol Venereol. 2019; 33(6):987-1005. DOI: 10.1111/jdv.15497. View

18.

Han Y, Tuan T, Wu H, Hughes M, Garner W . TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci. 2000; 114(Pt 1):131-139. PMC: 2435089. DOI: 10.1242/jcs.114.1.131. View

19.

Burgess C . Principles of soft tissue augmentation for the aging face. Clin Interv Aging. 2007; 1(4):349-55. PMC: 2699635. DOI: 10.2147/ciia.2006.1.4.349. View

20.

Huerth K, Hassan S, Callender V . Therapeutic Insights in Melasma and Hyperpigmentation Management. J Drugs Dermatol. 2019; 18(8):718-729. View